{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:52:30Z","timestamp":1740142350527,"version":"3.37.3"},"reference-count":29,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100003996","name":"Joint Research Programs of Yunnan Provincial Science and Technology Department and Kunming Medical University","doi-asserted-by":"publisher","award":["2017FE468-023","U0120160401"],"award-info":[{"award-number":["2017FE468-023","U0120160401"]}],"id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007846","name":"Scientific Research Program of Yunnan Provincial Education Department","doi-asserted-by":"publisher","award":["2015Y148","201622X089"],"award-info":[{"award-number":["2015Y148","201622X089"]}],"id":[{"id":"10.13039\/501100007846","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAD"],"published-print":{"date-parts":[[2020,6,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>B-RafV600E kinase was identified as an important target in current cancer treatment,\nand the type II B inhibitors show good qualities in preclinical studies. Therefore, it is very important\nto discover novel II B inhibitors of B-RafV600E kinase.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> In order to discover novel II B inhibitors of B-RafV600E kinase, virtual screening against ZINC\ndatabase was performed by using a combination of pharmacophore modelling, molecular docking, 3DQSAR\nmodel and binding free energy (\u0394Gbind) calculation studies. The inhibitory activities against A375\ncell lines of the hit compounds were tested by using MTT assay.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Five promising hit compounds were obtained after screening, and all the five hit compounds\nshowed good inhibitory rates against A375 cell lines.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The combined approach of the virtual screening in our work is effective, which can be used to\ndiscover novel inhibitors with a new skeleton. In addition, the five compounds obtained from the screening\nshowed good inhibitory rates against A375 cell lines, which can be considered to develop new II B inhibitors\nof B-RafV600E kinase.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573409915666190130162821","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T11:06:29Z","timestamp":1549019189000},"page":"222-230","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Virtual Screening for Type II B Inhibitors of B-Raf<sup>V600E<\/sup> Kinase"],"prefix":"10.2174","volume":"16","author":[{"given":"Kai-Xiong","family":"Qiu","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry, School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan 650500, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan 650500, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan 650500, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan 650500, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong-Wen","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan 650500, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Qun","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Kunming, Yunnan 650201, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Juan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan 650500, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Ding","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, School of Pharmaceutical Science & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan 650500, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nrm1498","volume":"5","author":"Wellbrock C.","year":"2004","unstructured":"Wellbrock C.; Karasarides M.; Marais R.; The RAF proteins take centre stage. Nat Rev Mol Cell Biol 2004,5(11),875-885","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=2","first-page":"452","volume":"8","author":"Li N.","year":"2007","unstructured":"Li N.; Batt D.; Warmuth M.; B-Raf kinase inhibitors for cancer treatment. Curr Opin Investig Drugs 2007,8(6),452-456","journal-title":"Curr Opin Investig Drugs"},{"key":"ref=3","first-page":"25","volume":"1653","author":"Mercer K.E.","year":"2003","unstructured":"Mercer K.E.; Pritchard C.A.; Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim Biophys Acta 2003,1653(1),25-40","journal-title":"Biochim Biophys Acta"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S0092-8674(04)00215-6","volume":"116","author":"Wan P.T.","year":"2004","unstructured":"Wan P.T.; Garnett M.J.; Roe S.M.; Lee S.; Niculescu-Duvaz D.; Good V.M.; Jones C.M.; Marshall C.J.; Springer C.J.; Barford D.; Marais R.; Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell Cancer Genome Project2004,116(6),855-867","journal-title":"Cell"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nature03095","volume":"432","author":"Sawyers C.","year":"2004","unstructured":"Sawyers C.; Targeted cancer therapy. Nature 2004,432(7015),294-297","journal-title":"Nature"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bcp.2017.02.022","volume":"132","author":"Wang P.F.","year":"2017","unstructured":"Wang P.F.; Qiu H.Y.; Wang Z.F.; Zhang Y.J.; Wang Z.C.; Li D.D.; Zhu H.L.; Identification of novel B-Raf inhibitors employing FBDD strategy. Biochem Pharmacol 2017,132,63-76","journal-title":"Biochem Pharmacol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.bmc.2018.03.038","volume":"26","author":"Wang P.F.","year":"2018","unstructured":"Wang P.F.; Zhang Y.J.; Wang D.; Hu H.M.; Wang Z.C.; Xu C.; Qiu H.Y.; Zhu H.L.; Design, synthesis, and biological evaluation of new B-Raf kinase inhibitors. Bioorg Med Chem 2018,26(9),2372-2380","journal-title":"Bioorg Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"7332","DOI":"10.1021\/jm300613w","volume":"55","author":"Wang X.","year":"2012","unstructured":"Wang X.; Kim J.; Conformation-specific effects of Raf kinase inhibitors. J Med Chem 2012,55(17),7332-7341","journal-title":"J Med Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ejmech.2013.11.018","volume":"72","author":"El-Nassan H.B.","year":"2014","unstructured":"El-Nassan H.B.; Recent progress in the identification of BRAF inhibitors as anti-cancer agents. Eur J Med Chem 2014,72,170-205","journal-title":"Eur J Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1016\/j.bmcl.2012.04.015","volume":"22","author":"Ren L.","year":"2012","unstructured":"Ren L.; Ahrendt K.A.; Grina J.; Laird E.R.; Buckmelter A.J.; Hansen J.D.; Newhouse B.; Moreno D.; Wenglowsky S.; Dinkel V.; Gloor S.L.; Hastings G.; Rana S.; Rasor K.; Risom T.; Sturgis H.L.; Voegtli W.C.; Mathieu S.; The discovery of potent and selective pyridopyrimidin-7-one based inhibitors of B-RafV600E kinase. Bioorg Med Chem Lett 2012,22(10),3387-3391","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.bmcl.2014.03.007","volume":"24","author":"Wenglowsky S.","year":"2014","unstructured":"Wenglowsky S.; Ren L.; Grina J.; Hansen J.D.; Laird E.R.; Moreno D.; Dinkel V.; Gloor S.L.; Hastings G.; Rana S.; Rasor K.; Sturgis H.L.; Voegtli W.C.; Vigers G.; Willis B.; Mathieu S.; Rudolph J.; Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-Raf(V600E) kinase. Bioorg Med Chem Lett 2014,24(8),1923-1927","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1021\/ml200025q","volume":"2","author":"Wenglowsky S.","year":"2011","unstructured":"Wenglowsky S.; Ren L.; Ahrendt K.A.; Laird E.R.; Aliagas I.; Alicke B.; Buckmelter A.J.; Choo E.F.; Dinkel V.; Feng B.; Gloor S.L.; Gould S.E.; Gross S.; Gunzner-Toste J.; Hansen J.D.; Hatzivassiliou G.; Liu B.; Malesky K.; Mathieu S.; Newhouse B.; Raddatz N.J.; Ran Y.; Rana S.; Randolph N.; Risom T.; Rudolph J.; Savage S.; Selby L.T.; Shrag M.; Song K.; Sturgis H.L.; Voegtli W.C.; Wen Z.; Willis B.S.; Woessner R.D.; Wu W.I.; Young W.B.; Grina J.; Pyrazolopyridine Inhibitors of B-Raf(V600E). Part 1: The Development of Selective, Orally Bioavailable, and Efficacious Inhibitors. ACS Med Chem Lett 2011,2(5),342-347","journal-title":"ACS Med Chem Lett"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1021\/jm300016v","volume":"55","author":"Mathieu S.","year":"2012","unstructured":"Mathieu S.; Gradl S.N.; Ren L.; Wen Z.; Aliagas I.; Gunzner-Toste J.; Lee W.; Pulk R.; Zhao G.; Alicke B.; Boggs J.W.; Buckmelter A.J.; Choo E.F.; Dinkel V.; Gloor S.L.; Gould S.E.; Hansen J.D.; Hastings G.; Hatzivassiliou G.; Laird E.R.; Moreno D.; Ran Y.; Voegtli W.C.; Wenglowsky S.; Grina J.; Rudolph J.; Potent and selective aminopyrimidine-based B-Raf inhibitors with favorable physicochemical and pharmacokinetic properties. J Med Chem 2012,55(6),2869-2881","journal-title":"J Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10822-006-9082-y","volume":"20","author":"Richmond N.J.","year":"2006","unstructured":"Richmond N.J.; Abrams C.A.; Wolohan P.R.N.; Abrahamian E.; Willett P.; Clark R.D.; GALAHAD: 1. pharmacophore identification by hypermolecular alignment of ligands in 3D. J Comput Aided Mol Des 2006,20(9),567-587","journal-title":"J Comput Aided Mol Des"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s10822-006-9070-2","volume":"20","author":"Shepphird J.K.","year":"2006","unstructured":"Shepphird J.K.; Clark R.D.; A marriage made in torsional space: using GALAHAD models to drive pharmacophore multiplet searches. J Comput Aided Mol Des 2006,20(12),763-771","journal-title":"J Comput Aided Mol Des"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2174\/157018008785777289","volume":"5","author":"Andrade C.H.","year":"2008","unstructured":"Andrade C.H.; Salum L.B.; Pasqualoto K.F.M.; Ferreira E.I.; Andricopulo A.D.; Three-dimensional quantitative structure-activity relationships for a large series of potent antitubercular agents. Lett Drug Des Discov 2008,5,377-387","journal-title":"Lett Drug Des Discov"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"5959","DOI":"10.1021\/ja00226a005","volume":"110","author":"Cramer R.D.","year":"1988","unstructured":"Cramer R.D.; Patterson D.E.; Bunce J.D.; Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 1988,110(18),5959-5967","journal-title":"J Am Chem Soc"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1021\/jm00050a010","volume":"37","author":"Klebe G.","year":"1994","unstructured":"Klebe G.; Abraham U.; Mietzner T.; Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 1994,37(24),4130-4146","journal-title":"J Med Chem"},{"year":"2012","author":"Case D.A.","key":"ref=19","unstructured":"Case D.A.; Darden T.A.; Cheatham T.E.; Simmerling C.L.; Wang J.; Duke R.E.; Luo R.; Walker R.C.; Zhang W.; Merz K.M.; AMBER 12, University of California, San Francisco, CA,\n  USA 2012"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/(SICI)1096-987X(20000130)21:2<132:AID-JCC5>3.0.CO;2-P","volume":"21","author":"Jakalian A.","year":"2000","unstructured":"Jakalian A.; Bush B.L.; Jack D.B.; Bayly C.I.; Fast, efficient generation of high-quality atomic charges. AM1-BCC model: I. Method. J Comput Chem 2000,21,132-146","journal-title":"J Comput Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"Jorgensen W.L.","year":"1983","unstructured":"Jorgensen W.L.; Chandrasekhar J.; Madura J.D.; Impey R.W.; Klein M.L.; Comparison of simple potential functions for simulating liquid water. J Chem Phys 1983,79,926-935","journal-title":"J Chem Phys"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","volume":"23","author":"Ryckaert J.P.","year":"1977","unstructured":"Ryckaert J.P.; Ciccotti G.; Berendsen H.J.C.; Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. J Comput Phys 1977,23,327-341","journal-title":"J Comput Phys"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"Miller B.R.","year":"2012","unstructured":"Miller B.R.; McGee T.D.; Swails J.M.; Homeyer N.; Gohlke H.; Roitberg A.E.; MMPBSA.py: An efficient program for end-state free energy calculations. J Chem Theory Comput 2012,8(9),3314-3321","journal-title":"J Chem Theory Comput"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jmgm.2010.08.005","volume":"29","author":"Caballero J.","year":"2010","unstructured":"Caballero J.; 3D-QSAR (CoMFA and CoMSIA) and pharmacophore (GALAHAD) studies on the differential inhibition of aldose reductase by flavonoid compounds. J Mol Graph Model 2010,29(3),363-371","journal-title":"J Mol Graph Model"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"Irwin J.J.","year":"2005","unstructured":"Irwin J.J.; Shoichet B.K.; ZINC--a free database of commercially available compounds for virtual screening. J Chem Inf Model 2005,45(1),177-182","journal-title":"J Chem Inf Model"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"12307","DOI":"10.3390\/ijms160612307","volume":"16","author":"Xie H.","year":"2015","unstructured":"Xie H.; Chen L.; Zhang J.; Xie X.; Qiu K.; Fu J.; A combined pharmacophore modeling, 3D QSAR and virtual screening studies on imidazopyridines as B-Raf inhibitors. Int J Mol Sci 2015,16(6),12307-12323","journal-title":"Int J Mol Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1021\/jm020406h","volume":"46","author":"Jain A.N.","year":"2003","unstructured":"Jain A.N.; Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. J Med Chem 2003,46(4),499-511","journal-title":"J Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ci100275a","volume":"51","author":"Hou T.","year":"2011","unstructured":"Hou T.; Wang J.; Li Y.; Wang W.; Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model 2011,51(1),69-82","journal-title":"J Chem Inf Model"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1535-6108(03)00189-2","volume":"4","author":"Tuveson D.A.","year":"2003","unstructured":"Tuveson D.A.; Weber B.L.; Herlyn M.; BRAF as a potential therapeutic target in melanoma and other malignancies. Cancer Cell 2003,4(2),95-98","journal-title":"Cancer Cell"}],"container-title":["Current Computer-Aided Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/169488","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:49:12Z","timestamp":1594957752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/169488\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,2]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573409915666190130162821","relation":{},"ISSN":["1573-4099"],"issn-type":[{"type":"print","value":"1573-4099"}],"subject":[],"published":{"date-parts":[[2020,6,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-08-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}